Genetic Technologies (ASX:GTG) Other Gross PPE : A$1.21 Mil (As of Jun. 2024)

View and export this data going back to 1987. Start your Free Trial

What is Genetic Technologies Other Gross PPE?

Genetic Technologies's Other Gross PPE for the quarter that ended in Jun. 2024 was A$1.21 Mil.

Genetic Technologies's quarterly Other Gross PPE declined from Dec. 2023 (A$0.43 Mil) to Mar. 2024 (A$0.00 Mil) but then increased from Mar. 2024 (A$0.00 Mil) to Jun. 2024 (A$1.21 Mil).

Genetic Technologies's annual Other Gross PPE declined from Jun. 2022 (A$1.62 Mil) to Jun. 2023 (A$1.48 Mil) and declined from Jun. 2023 (A$1.48 Mil) to Jun. 2024 (A$1.21 Mil).

Genetic Technologies Other Gross PPE Historical Data

The historical data trend for Genetic Technologies's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Technologies Other Gross PPE Chart

Genetic Technologies Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Gross PPE

Get a 7-Day Free Trial

2.91

1.14

1.62

1.48

1.21

Genetic Technologies Quarterly Data
	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Gross PPE	Get a 7-Day Free Trial															-	0.43	-	1.21	-

Genetic Technologies Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Genetic Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Technologies Ltd (ASX:GTG) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

GENE:USA 0A4N:UK DU8:Germany

Address

60-66 Hanover Street, Fitzroy, Melbourne, VIC, AUS, 3065

Website

https://www.gtglabs.com

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.

Genetic Technologies Headlines

No Headlines